Healthy men test two versions of fertility drug in bioequivalence study
NCT ID NCT07097259
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new liquid form of follitropin alfa (a hormone used for fertility) works the same as the standard powder form. Fifty-five healthy men with low testosterone levels were given both versions at different times. The goal was to compare how the drug is absorbed by the body, not to treat any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOGONADISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ICON Early Phase Services, LLC_Clinic San Antonio
San Antonio, Texas, 78209, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Testosterone may rebuild strength after spinal cord injury — trial puts it to the test
- Fertility study asks: are men still overlooked in IVF clinics?
- Can a cheap breast cancer drug fix hormone recovery in prostate cancer patients?
- Could a testosterone shot before surgery speed recovery?
- Testosterone Therapy's heart risk under the microscope
- Could pollution and sleep habits be messing with your hormones? new study investigates.